Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox

Blood

Volumn 91, Issue 5, 1998, Pages 1582-1589

  Chang, Mei Chi ^b   Lin, Hui Kuan ^b   Peng, Hui Chin ^b   Huang, Tur Fu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FLUORESCEIN SODIUM; GLYCOPROTEIN IB; IODINE 125; MONOCROTALINE; RISTOCETIN; SNAKE VENOM; THROMBOXANE B2; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; THROMBOSIS PREVENTION;

EID: 0032031490     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.5.1582.1582_1582_1589     Document Type: Article

References (42)

1. Huang TF, Chang MC, Teng CM: Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib. Biochim Biophys Acta 1158:293, 1993
2. Clemetson JK, Clemetson JM: Platelet GPIb-V-IX complex: Structure, function, physiology and pathology. Semin Thromb Hemost 21:130, 1995
3. de Groot PG: Platelet adhesion. Br J Haematol 75:308, 1990
4. Roth GJ: Platelet and blood vessels; the adhesion event. Immunol Today 13:100, 1992
5. Sakariassen KS, Fressinaud E, Girmo J-P, Mayer D, Baumgartner HR: Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen. Ann NY Acad Sci 516:52, 1987
6. Sixma JJ, Nievelstein FEM, Zwaginga J-J, de Groot PG: Adhesion of blood platelets to the extracellular matrix of cultured human endothelial cells. Ann NY Acad Sci 516:39, 1987
7. Coller BS, Anderson K, Weisman HF: New antiplatelet agents: Platelet GPIIb/IIIa antagonists. Thromb Haemost 74:302, 1995
8. 2 and serotonin S2-receptor antagonists markedly enhances thormbolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary throbosis. Circulation 79:911, 1989
9. Nichols AJ, Ruffolo RR, Huffman WF, Poste G, Samanen J: Development of GPIIb/IIIa antagonists as antithrombotic drugs. Trends Pharmacol 13:413, 1992
10. Fenton JW: Thrombin. Ann NY Acad Sci 485:5, 1984
11. Heras M, Chesebro JH, Webster NIW, Mruk JS, Grill DE, Penny WJ, Bowie EJW, Badimon L, Fuster V: Hirudin heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Circulation 82:1476, 1990
12. Jang IK, Gold HK, Ziskind AA, Leinbach RC, Fallon JT, Collen D: Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation 81:219, 1990
13. Eidt JF, Allison P, Noble S, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT: Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 84:18, 1989
14. Teng CM, Huang TF: Inventory of exogenous inhibitors of platelet aggregation. Thromb Haemost 65:624, 1991
15. Huang TF, Niewiarowski S: Disintegrins: The naturally-occurring antagonists of platelet fibrinogen receptor. J Toxicol-Toxin Rev 13:253, 1994
16. Read MS, Shermer RW, Brinkhous KM: Venom coagglutinin: An activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 75:4514, 1978
17. Brinkhous KM, Read MS, Fricke WA, Wagner RH: Botrocetin (venom coagulatinin): Reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci USA 80:1463, 1983
18. Peng M, Lu W, Beviglia L, Niewiarowski S, Kirby EP: Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 81:2321, 1993
19. Fujimura Y, Miura IS, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T: Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost 74:743, 1995
20. Fujimura Y, Kawasaki T, Titani K: Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 76:633, 1996
21. Sheu JR, Chao SH, Yen MH. Huang TF: In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice. Thromb Haemost 72:617, 1994
22. Newmans J, Johnson AJ, Karpatkin MH, Puszkin S: Methods for the production of clinically effective intermediate and high-purity factor-VIII concentrates. Br J Haematol 21:1, 1971
23. Born GVR, Cross MJ: The aggregation of blood platelets. J Physiol 168:178, 1963
24. Kornecki E, Niewiarowski S, Morinelli TA, Kloczewialc M: Effect of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on the normal human and Glanzmann's thrombathenic platelets. J Biol Chem 256:5696, 1981
25. Niewiarowski S, Budzynsti AZ, Morinelli TA, Brudzynski TM, Stewart GJ: Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem 256:917, 1981
26. Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660, 1949
27. Dejana E, Villa S, de Gaetano G: Bleeding time in rats: A comparison of different experimental conditions. Thromb Haemost 48:108, 1982
28. Sato M, Ohshima N: Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvessels of the rat. Thromb Res 35:319, 1984
29. Chang MC, Huang TF: In vivo effect of a thrombin-like enzyme on platelet plug formation induced in mesenteric microvessels of mice. Thromb Res 73:31, 1994
30. Huang TF, Liu CZ, Ouyang C, Teng CM: Halysin, an antiplatelet Arg-Gly-Asp containing snake venom peptide, as fibrinogen receptor antagonist. Biochem Pharmacol 42:1209, 1991
31. Gralnick HR, Williams SB, Coller BS: Asial von Willebrand factor interactions with platelets: Interdependence of glycoprotein Ib and IIb/IIIa for binding and aggregation. J Clin Invest 75:19, 1985
32. Tanoue K, Jung SM, Yamamoto N, Yamazaki H: Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination. Thromb Haemost 51:79, 1984
33. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AS: von Willebrand factor binding to platelet GPIb initiates signals for platelet activation. J Clin Invest 88:1568, 1990
34. Kawakami K, Harada Y, Sakasita M, Nagai H, Handa M, Ikeda Y: A new method for continuous measurement of platelet adhesion under flow conditions. ASAIO J 39:M558, 1993
35. Sadler JE: von Willebrand factor. J Biol Chem 266:18172, 1991
36. Girma JP. Meyer D, Verweij CL, Pannekoek H, Sixma JJ: Structure-function relationship of human von Willebrand factor. Blood 70:605, 1987
37. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM: The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Proc Natl Acad Sci USA 261:12579, 1986
38. Cruz MA, Peterson E, Turci SM, Handin RI: Functional analysis of a recombinant glycoprotein Ibα polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein Ib-IX complex and to collagen. J Biol Chem 267:1303, 1992
39. Strony J, Song A, Rusterholtz L, Adelman B: Aurintricarboxylic acid prevents acute rethrombosis in a canine model of arterial thrombosis. Arterioscler Thromb Vase Biol 15:359, 1995
40. Sheu JR, Yen MH, Peng HC, Chang MC, HuangTF: Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments. Eur J Pharmacol 294:231, 1995
41. Mustard JF, Perry DW, Ardlie NG, Packham MA: Preparation of suspensions of washed platelets from humans. Br J Haematol 22:193, 1972
42. Harmon JT, Jamieson GA: The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites in thrombin. J Biol Chem 261:13224, 1986